Latest PR - Double story - with images
View AllMarine Engineering & Contracting
May 13, 2026
DEME Trading Update 1st Quarter 2026: Solid start to the year
Marine Engineering & Contracting
May 12, 2026
DEME adds Norse Energi to its next-generation fleet
Growth Capital
May 06, 2026
Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors
Growth Capital
April 30, 2026
Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554
Latest PR - Double story - no images
View AllMarine Engineering & Contracting
May 13, 2026
DEME Trading Update 1st Quarter 2026: Solid start to the year
Marine Engineering & Contracting
May 12, 2026
DEME adds Norse Energi to its next-generation fleet
Growth Capital
May 06, 2026
Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors
Growth Capital
April 30, 2026
Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554
Latest PR - Triple story - with images
View AllMarine Engineering & Contracting
May 13, 2026
DEME Trading Update 1st Quarter 2026: Solid start to the year
Marine Engineering & Contracting
May 12, 2026
DEME adds Norse Energi to its next-generation fleet
Growth Capital
May 06, 2026
Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors
Growth Capital
April 30, 2026
Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554
Latest PR - Triple story - no images
View AllMarine Engineering & Contracting
May 13, 2026
DEME Trading Update 1st Quarter 2026: Solid start to the year
Marine Engineering & Contracting
May 12, 2026
DEME adds Norse Energi to its next-generation fleet
Growth Capital
May 06, 2026
Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors
Growth Capital
April 30, 2026